This blog post discusses Sovaldi (sofosbuvir), an oral drug recently approved by the FDA for the treatment of chronic hepatitis C, and the potential impact of this long-awaited cure on Medicare spending and Part D premiums.
- state & global data
- view as grid
- view as list
This report presents data on changes in Medicaid’s enrollment and spending between federal fiscal year 2007 and federal fiscal year 2012, a period which includes the worst economic downturn in the United States since the Great Depression. The paper also examines what factors drove Medicaid spending over the period, and concludes that overall spending growth from 2007 to 2012 was driven largely by the enrollment growth that resulted from many people losing jobs and income during the recession. However, on a per enrollee basis, Medicaid spending has grown more slowly than other sectors of the health system.
This policy insight examines the unexpected drop in Medicare’s per-beneficiary spending projections and its implications for beneficiaries and the program’s future.
Headlines regularly call attention to pockets of fraudulent activity in the health care arena – scams that amount to millions and potentially billions of dollars. The stories typically focus on catching the crooks but not so much on efforts to prevent fraud, waste and abuse in health care programs. Both…
The Alliance for Health Reform and the Kaiser Family Foundation co-sponsored this briefing to have a panel of experts answer questions about how public support for health reform waxes and wanes depending, not only on what’s being proposed in the reform proposals, but also on who asks the question and…
Panelists at this briefing examine what’s happening behind the scenes to implement the Patient Protection and Affordable Care Act. An overview of federal policymaking and the efforts by stakeholders and others to affect final policies pertaining to the health reform law is provided. The session will look into key tools…